% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Hammes:20155,
author = {Hammes, J. and Pietrzyk, U. and Schmidt, M. and Schicha, H.
and Eschner, W.},
title = {{GATE} based {M}onte {C}arlo simulation of planar
scintigraphy to estimate the nodular dose in radioiodine
therapy for autonomous thyroid adenoma},
journal = {Zeitschrift für Medizinische Physik},
volume = {21},
issn = {0939-3889},
address = {Amsterdam [u.a.]},
publisher = {Elsevier},
reportid = {PreJuSER-20155},
pages = {290 - 300},
year = {2011},
note = {Record converted from VDB: 12.11.2012},
abstract = {The recommended target dose in radioiodine therapy of
solitary hyperfunctioning thyroid nodules is 300-400Gy and
therefore higher than in other radiotherapies. This is due
to the fact that an unknown, yet significant portion of the
activity is stored in extranodular areas but is neglected in
the calculatory dosimetry. We investigate the feasibility of
determining the ratio of nodular and extranodular activity
concentrations (uptakes) from post-therapeutically acquired
planar scintigrams with Monte Carlo simulations in GATE. The
geometry of a gamma camera with a high energy collimator was
emulated in GATE (Version 5). A geometrical thyroid-neck
phantom (GP) and the ICRP reference voxel phantoms "Adult
Female" (AF, 16ml thyroid) and "Adult Male" (AM, 19ml
thyroid) were used as source regions. Nodules of 1ml and 3ml
volume were placed in the phantoms. For each phantom and
each nodule 200 scintigraphic acquisitions were simulated.
Uptake ratios of nodule and rest of thyroid ranging from 1
to 20 could be created by summation. Quantitative image
analysis was performed by investigating the number of
simulated counts in regions of interest (ROIs). ROIs were
created by perpendicular projection of the phantom onto the
camera plane to avoid a user dependant bias. The ratio of
count densities in ROIs over the nodule and over the
contralateral lobe, which should be least affected by
nodular activity, was taken to be the best available measure
for the uptake ratios. However, the predefined uptake ratios
are underestimated by these count density ratios: For an
uptake ratio of 20 the count ratios range from 4.5 (AF, 1ml
nodule) to 15.3 (AM, 3ml nodule). Furthermore, the
contralateral ROI is more strongly affected by nodular
activity than expected: For an uptake ratio of 20 between
nodule and rest of thyroid up to $29\%$ of total counts in
the ROI over the contralateral lobe are caused by decays in
the nodule (AF 3 ml). In the case of the 1ml nodules this
effect is smaller: $9-11\%$ (AF) respectively $7-8\%$ (AM).
For each phantom, the dependency of count density ratios
upon uptake ratios can be modeled well by both linear and
quadratic regression (quadratic: r(2)>0.99), yielding sets
of parameters which in reverse allow the computation of
uptake ratios (and thus dose) from count density ratios. A
single regression model obtained by fitting the data of all
simulations simultaneously did not provide satisfactory
results except for GP, while underestimating the true uptake
ratios in AF and overestimating them in AM. The
scintigraphic count density ratios depend upon the uptake
ratios between nodule and rest of thyroid, upon their
volumes, and their respective position in a non-trivial way.
Further investigations are required to derive a
comprehensive rule to calculate the uptake or dose ratios
based on post-therapeutic scintigraphy.},
keywords = {Adult / Female / Humans / Iodine Radioisotopes:
administration $\&$ dosage / Iodine Radioisotopes:
pharmacokinetics / Monte Carlo Method / Phantoms, Imaging /
Radiometry: methods / Radionuclide Imaging: methods /
Radiotherapy Planning, Computer-Assisted: methods / Thyroid
Gland: radiation effects / Thyroid Gland: radionuclide
imaging / Thyroid Neoplasms: radionuclide imaging / Thyroid
Neoplasms: radiotherapy / Thyroid Nodule: radionuclide
imaging / Thyroid Nodule: radiotherapy / Iodine
Radioisotopes (NLM Chemicals) / J (WoSType)},
cin = {INM-4},
ddc = {610},
cid = {I:(DE-Juel1)INM-4-20090406},
pnm = {Neurowissenschaften},
pid = {G:(DE-Juel1)FUEK255},
shelfmark = {Radiology, Nuclear Medicine $\&$ Medical Imaging},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:21983024},
UT = {WOS:000299444800008},
doi = {10.1016/j.zemedi.2011.09.002},
url = {https://juser.fz-juelich.de/record/20155},
}